Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/2007
11/06/2007US7291334 antibodies that bind to immunogens for diagnosis of enterotoxigenic E. coli infections such as traveler's diarrhea; kits
11/06/2007US7291332 Inflammatory mediator antagonists
11/06/2007US7291329 Antibodies against PRO4406
11/06/2007US7291325 Method for producing target proteins by deleting or amplifying ibpA and/or ibpB gene coding for inclusion body-associated proteins
11/06/2007CA2363713C Lantibiotic
11/06/2007CA2206599C Method and device for separating fibrin i from blood plasma
11/06/2007CA2182795C Superactive vip antagonists
11/06/2007CA2170236C Inducing antibody response against self-proteins with the aid of foreign t-cell epitopes
11/06/2007CA2168011C Hybrid toxin
11/06/2007CA2159614C Control of plant abscission and pod dehiscence
11/06/2007CA2114251C Igf-1 to improve the neural condition
11/06/2007CA2113089C Universal donor cells
11/06/2007CA2079881C Nucleotidic sequences coding for variable regions of .beta. chains of human t lymphocite receptors, corresponding peptidic segments and diagnostic and therapeutic applications
11/06/2007CA2079879C Nucleotidic sequences coding for alpha chain variable regions in human lymphocite receptors and applications thereof
11/01/2007WO2007124486A2 Bmp4 inhibitors
11/01/2007WO2007124464A2 Thermostable proteins and methods of making and using thereof
11/01/2007WO2007124463A1 Glp-1 compound/glucagon antibody compositions
11/01/2007WO2007124461A2 Glp-1 compounds
11/01/2007WO2007124186A2 Expression control elements from the lemnaceae family
11/01/2007WO2007124133A2 Methods and compositions based on shiga toxin type 1 protein
11/01/2007WO2007124115A2 Compositions and methods for identifying inhibitors and activators of cyclic amp phosphodiesterases
11/01/2007WO2007123850A2 Recombinant attenuated clostridium organisms and vaccine
11/01/2007WO2007123791A2 Methods of determining cellular chemosensitivity
11/01/2007WO2007123689A1 Expression, secretion and purification of recombinant bovine serum albumin (rbsa) and uses thereof
11/01/2007WO2007123591A1 Ctsp cancer-testis antigens
11/01/2007WO2007123498A2 MUTATED TRUNCATED MT-PFKA GENE FOR THE SYNTHESIS OF ACTIVE SHORTER FRAGMENT OF 6-PHOSPHOFRUCTO-l-KINASE
11/01/2007WO2007123489A1 Method for recombinant protein production in cho cells
11/01/2007WO2007122975A1 Hgf precursor protein mutant and activated form thereof
11/01/2007WO2007122760A1 Detection reagent and detection method for influenza infection
11/01/2007WO2007122622A1 Method of treatment of a disease
11/01/2007WO2007122447A1 CYCLODIPEPTIDE SYNTHETASE AND ITS USE FOR SYNTHESIS OF CYCLO(TYR-Xaa) CYCLODIPEPTIDES
11/01/2007WO2007122446A1 Cyclodipeptide synthetases and their use for synthesis of cyclo(leu-leu) cyclodipeptide
11/01/2007WO2007122424A2 Larval polypeptides having a nuclease activity
11/01/2007WO2007122400A2 Novel polypeptides and use thereof
11/01/2007WO2007122249A1 Production of compounds in a recombinant host
11/01/2007WO2007122247A1 A sex-specific marker for shrimps and prawns
11/01/2007WO2007122179A1 Hydrolysate of avian cartilage, process of preparation and uses thereof
11/01/2007WO2007122086A1 Transgenic plants and methods for controlling bolting in sugar beet
11/01/2007WO2007121895A2 Hpv-16-based papillomavirus vaccine
11/01/2007WO2007121894A2 Hpv-18-based papillomavirus vaccine
11/01/2007WO2007121600A1 Nucleic acid, polypeptide and its use
11/01/2007WO2007121576A1 Methods of inducing apoptosis of cancerous cells using apoptin derivatives
11/01/2007WO2007121512A1 Insect olfactory receptors
11/01/2007WO2007121491A1 Hcv vaccinations
11/01/2007WO2007104567A3 Pegylated mutated clostridium botulinum toxin
11/01/2007WO2007098717A3 Chimeric vaccine antigens against classical swine fever virus
11/01/2007WO2007090123A3 Mgra is a redox regulator of antibiotic sensitivity and virulence
11/01/2007WO2007087521A3 Cd86 and cd80 receptor competition assays
11/01/2007WO2007087279A3 Methods for breeding glyphosate resistant plants and compositions thereof
11/01/2007WO2007075899A8 Dual agonist compounds and uses thereof
11/01/2007WO2007074457A3 Histidine-containing diastereomeric peptides and uses thereof
11/01/2007WO2007062037A3 Compositions and methods of producing hybrid antigen binding molecules and uses thereof
11/01/2007WO2007060514A3 Methods and compositions for modulating root growth in plants
11/01/2007WO2007030290A3 Cristin/r-spondin ligands active in the wnt signaling pathway and methods, compositions and kits relating thereto
11/01/2007WO2006135738A3 Devices from prion-like proteins
11/01/2007WO2006097564A8 Novel soluble epcr protein of non-proteolytic origin and use thereof
11/01/2007WO2005118820A3 Nucleotide sequences and polypeptides encoded thereby useful for modifying plant characteristics
11/01/2007WO2003105886A3 Methods and uses of the integrin alpha 10 chain, for preventing progression of atherosclerosis plaque formation
11/01/2007WO2003091411A3 Semisynthetic protein-based site-directed probes for identification and inhibition of active sites, and methods therefor
11/01/2007WO2002079435A3 Transgenic mice containing gpcr-like gene disruptions
11/01/2007WO2002016400A3 Haplotypes of the scya26 gene
11/01/2007US20070256196 Method of Modifying Plant Phenotypes With Nonsymbiotic Hemoglobin
11/01/2007US20070256194 Isolated nucleic acids encoding resistance polypeptides and uses thereof
11/01/2007US20070256149 Dep2 and its uses in major depressive disorder and other related disorders
11/01/2007US20070256148 DEP2 and its uses in major depressive disorder and other related disorders
11/01/2007US20070256147 Combinatorial marking of cells and cell structures with reconstituted fluorescent proteins
11/01/2007US20070256145 Mammalian transforming growth factor beta-9
11/01/2007US20070255044 Preparing immunoglobulins specific to galanin binding protein for use in treatment and prevention of nervous system disorders
11/01/2007US20070255043 MN gene and protein
11/01/2007US20070255041 Bioengineered Vehicles for Targeted Nucleic Acid Delivery
11/01/2007US20070254851 Chemically-defined non-polymeric valency platform molecules and conjugates thereof
11/01/2007US20070254844 biodrug contains an immunogenic peptide; encoded from an isolated host cell transfected with the recombinant expression vector; diagnosis of skin cancer; vaccine for prevention and treatment; immunotherapy
11/01/2007US20070254840 High Molecular Weight Derivatives of Vitamin K-Dependent Polypeptides
11/01/2007US20070254839 Orally administered peptides synergize statin activity
11/01/2007US20070254838 Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules
11/01/2007US20070254836 Glycopegylated Granulocyte Colony Stimulating Factor
11/01/2007US20070254834 Glycopegylated Erythropoietin
11/01/2007US20070254831 PEPTIDES THAT BLOCK THE BINDING OF IgG to FcRn
11/01/2007US20070254829 Compound Ws727713
11/01/2007US20070254373 Fragments of fluorescent proteins for protein fragment complementation assays
11/01/2007US20070254371 Peptide combos and their uses
11/01/2007US20070254360 Expression vector comprising nucleotide sequences coding dorsal-ventral patterning fusion protein for use as tool in enhancement of immune response in infected cells
11/01/2007US20070254351 Vessicular composition comprising hepatitis C virus RNA sequences for use in designing drugs for treatment and prevention of viral infection
11/01/2007US20070254339 Tetramerizing polypeptides and methods of use
11/01/2007US20070254336 Transcription Factors
11/01/2007US20070254329 Mammalian Genes Involved in Viral Infection and Tumor Suppression
11/01/2007US20070254321 Lytic Enzymes and Spore Surface Antigen for Detection and Treatment of Bacillus Anthracis Bacteria and Spores
11/01/2007US20070254313 Gnal Splice Variant and Uses Thereof
11/01/2007US20070254302 Compositions and methods for the diagnosis and treatment of tumor
11/01/2007US20070254300 Compositions and methods for treating inflammatory disorders
11/01/2007US20070254298 Atropisomers of asymmetric xanthene fluorescent dyes and method of dna sequencing and fragment analysis
11/01/2007US20070254297 KCNQ2 and KCNQ3 - potassium channel genes which are mutated in Benign Familial Neonatal Convulsions (BFNC) and other epilepsies
11/01/2007US20070254283 Brhf1 as a Cancer Diagnostic Marker
11/01/2007US20070253982 Compositions that include hemagglutinin, methods of making and methods of use thereof
11/01/2007US20070253981 Canine influenza virus
11/01/2007US20070253977 Recombinant respiratory syncytial virus (RSV) strains deleted of the region of G protein most likely to induce unwanted type 2 T cell responses in susceptible recipients; engineered using reverse genetics with deletions of amino acids 151-221 and 178-219; for immunogenic compositions against RSV
11/01/2007US20070253976 Compositions and methods comprising KLK3 of FOLH1 antigen
11/01/2007US20070253974 Elicits the production of antibodies that interfere with invasion by Babesia bovis into erythrocytes, diagnosis
11/01/2007US20070253972 For expressing foreign genetic information, e.g. foreign genes, for many applications, including immunogenic or pharmaceutical compositions for pathogens other than mumps, gene therapy, and cell targeting
11/01/2007US20070253971 Circovirus sequences associated with piglet weight loss disease (PWD)
1 ... 834 835 836 837 838 839 840 841 842 843 844 845 846 847 848 849 850 851 852 853 854 ... 2916